English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNYU Langone rheumatologists are presenting their discoveries at the annual American College of Rheumatology conference, November 1 to November 9. The conference will be held virtually.
Tag: American College of Rheumatology Annual Meeting
Romosozumab Substantially Builds Bone Density in Hip and Spine, With Even More Gains When Followed by Antiresorptive Drug
New research presented at ACR Convergence, the American College Rheumatology’s annual meeting, reveals that romosozumab, an osteoporosis drug, produces substantial gains in bone mineral density in the hip and lumbar spine within one year, and that transitioning patients to a potent antiresorptive drug can lead to even more bone density gains.
Tuberculosis Screening Needed for Methotrexate Users in At-Risk Locales
New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that tuberculosis (TB) screening and ongoing clinical care is needed for people on methotrexate who live in areas where the highly infectious illness is common. Methotrexate users who also take corticosteroids or other immunosuppressant therapies are at particular risk and need adequate TB screening.
With Close Monitoring Throughout, Safe Pregnancy is Possible for Women with Interstitial Lung Disease
A new study shows that women with interstitial lung disease (ILD) related to autoimmune disease may not need to terminate their pregnancies provided they have close monitoring from their team of multidisciplinary physicians before, during and after pregnancy. Results of the research was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.
Hydroxychloroquine Has No Significant Impact on Heart Rhythm in Lupus Patients, Even Those with Chronic Kidney Disease
New research shows that adults with lupus who take hydroxychloroquine do not have any differences in their corrected QT (QTc) intervals even if they have chronic kidney disease. The study was presented at ACR Convergence, the American College Rheumatology’s annual meeting.
Osteoporosis Is Underdiagnosed and Undertreated in Older Men
A new study reveals that many older men who experience a fracture are still underdiagnosed with and undertreated for osteoporosis. Details of the study was presented at ACR Convergence, the American College Rheumatology’s annual meeting.
Warfarin Use Significantly Increases Risk of Knee and Hip Replacement in People with OA
New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that use of warfarin, a vitamin K drug widely prescribed to prevent blood clots, is associated with a significantly greater risk of knee and hip replacements in patients with osteoarthritis.
Steroid Injections Do Not Hasten the Need for Knee Replacement When Compared to Hyaluronic Acid Treatments for Adults with Knee OA
New research shows that corticosteroid injections for knee OA treatment do not hasten a patient’s progression to a total knee replacement when compared with hyaluronic acid injections. Details of this study was presented at ACR Convergence, the American College of Rheumatology’s annual meeting.
Hydroxychloroquine Not Linked to Longer Heart Rhythm Intervals in Rheumatoid Arthritis or Lupus Patients
New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, discovers that use of hydroxychloroquine does not cause any significant differences in QTc length or prolonged QTc in people with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE).
Telemedicine Reduces Cancellations and No-Shows for Rheumatology Care During COVID in Large Ohio Health System
New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that expanded use of telemedicine during COVID-19 improved cancellation rates, no-shows and completed medical visits for rheumatology ambulatory clinics in one large Ohio health system.